Kabra Drugs shareholders approve name change and object clause alteration
Kabra Drugs Limited shareholders have approved a change in the company's name and the alteration of its object clause through a postal ballot. The resolutions, passed on June 10, 2026, received 99.85% approval from 35 members casting 2,750,027 valid votes.
*this image is generated using AI for illustrative purposes only.
Kabra Drugs Limited shareholders have approved a change in the company's name and the alteration of its object clause. The resolutions were passed through a postal ballot conducted via remote e-voting, concluding on June 10, 2026. These approvals allow the company to rebrand and expand its operational objectives as outlined in its Memorandum of Association.
The postal ballot process was conducted in accordance with Sections 108 and 110 of the Companies Act, 2013, and relevant rules. The notice for the ballot was dated May 8, 2026, and the remote e-voting facility was provided by CDSL. The voting period commenced on May 12, 2026, and concluded on June 10, 2026.
Voting Results
The scrutinizer, CS Jay Arvind Jain of Jay Jain & Associates, verified the votes cast by shareholders. A total of 35 members participated, casting 2,750,027 valid votes. The results showed strong support for both special resolutions.
Resolution 1: Change in Name
| Particulars | Number of Members Voted | Number of valid votes cast | % of total valid votes |
|---|---|---|---|
| In favor | 34 | 2,746,027 | 99.85 |
| In against | 1 | 4,000 | 0.15 |
| Total | 35 | 2,750,027 | 100.00 |
Resolution 2: Alteration of Object Clause
| Particulars | Number of Members Voted | Number of valid votes cast | % of total valid votes |
|---|---|---|---|
| In favor | 34 | 2,746,027 | 99.85 |
| In against | 1 | 4,000 | 0.15 |
| Total | 35 | 2,750,027 | 100.00 |
The resolutions were deemed passed on June 10, 2026, with the requisite majority. The company will now proceed with the necessary regulatory steps to implement the name change and the alteration of the object clause.
Historical Stock Returns for Kabra Drugs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.10% | -6.40% | -5.41% | -21.46% | +71.55% | +339.81% |
What specific new sectors or business lines does Kabra Drugs plan to enter under the altered object clause?
When will the company announce the new brand name and launch its corresponding marketing strategy?
How will the rebranding impact the company's stock ticker symbol and trading liquidity in the short term?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
